InsiderTrades

Form 4 for INO INOVIO PHARMACEUTICALS, INC.

Accepted 2023-05-12 00:00:00 ET · period of report 2023-05-10 · accession 0001055726-23-000032 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-05-12 2023-05-10 INO Shea Jacqueline Elizabeth CEO, Dir F - Tax $0.81 -28.7K 198.1K -13% -$23.3K
D 2023-05-12 2023-05-10 INO Shea Jacqueline Elizabeth CEO, Dir M - OptEx — +66.0K 226.8K +41% —
D 2023-05-12 2023-05-10 INO Shea Jacqueline Elizabeth CEO, Dir M - OptEx $0.00 -66.0K 132.0K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-05-10 F D 28,704 $0.81 198,113 D — —
2 Common Common Stock 2023-05-10 M A 66,000 — 226,817 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 198,000 restricted stock units is as follows: 66,000 shares vested on May 10, 2023; 66,000 shares will vest on May 10, 2024; 66,000 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
3 Derivative Restricted Stock Unit 2023-05-10 M D 66,000 $0.00 132,000 D — · — to — 66,000 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 198,000 restricted stock units is as follows: 66,000 shares vested on May 10, 2023; 66,000 shares will vest on May 10, 2024; 66,000 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.